Let's not beat a dead horse. Gerald has stated INFINITE times that they are not going to arbitrarily initiate a RS at the present pps. Let's try to exercise a little integrity here. LYMPRO is going to begin energizing income this quarter that will do nothing but mushroom in the quarters ahead. Take a breather, cut the coffee, and go for a walk.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links